The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus ipilimumab (N+I) in patients (pts) with colorectal cancer (CRC) with high tumor mutational burden (hTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study.
 
Gina M. Vaccaro
Consulting or Advisory Role - Amgen; Array BioPharma; Astellas Pharma; AstraZeneca; Exelixis; Incyte; MSD; Pfizer; QED Therapeutics; Taiho Pharmaceutical
Speakers' Bureau - Incyte
Research Funding - Array BioPharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; E.R. Squibb Sons, LLC; Eisai; Foundation Medicine
 
Michael Rothe
Employment - Emmes
 
Pam K. Mangat
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
Consulting or Advisory Role - Deciphera
 
Jimmy J. Hwang
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Caris Centers of Excellence; Deciphera; Incyte; Pfizer; QED Therapeutics
Speakers' Bureau - Bristol-Myers Squibb; Deciphera; Incyte
Research Funding - Boehringer Ingelheim (Inst); Caris Centers of Excellence (Inst)
 
Olatunji B. Alese
Consulting or Advisory Role - Ipsen; Natera; Pathema GX; Pfizer; QED Therapeutics; Taiho Oncology
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Corcept Therapeutics (Inst); Hutchison MediPharma (Inst); Ipsen (Inst); MabSpace Biosciences (Inst); PCI Biotech (Inst); SynCoreBio (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
 
Maged F. Khalil
No Relationships to Disclose
 
Muhammad Khurram Hameed
Stock and Other Ownership Interests - Moderna Therapeutics
 
Herbert Leon Duvivier
Speakers' Bureau - AstraZeneca; Guardant Health
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Deciphera
Consulting or Advisory Role - Loxo; Navican
Other Relationship - Navican/ Intermountain Healthcare
 
Gina N. Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine
Consulting or Advisory Role - Bryologyx; Cellworks; EQRx; Illumina; Scandion Oncology
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)